In this episode of RhAPPcast, the official podcast of Rheumatology Advanced Practice Providers, host Amanda Mixon, PA-C, is joined by Wendy Simmons, PA-C, for Part 2 of the EULAR 2026 Osteoporosis RhAPP Up Series.

Together, they review key osteoporosis abstracts from the 2026 EULAR Congress, including new insights on the use of GLP-1 based therapies in patients taking oral bisphosphonates for osteoporosis and the potential impact on adverse events, medication tolerability, calcium absorption, and long-term bone health.

This episode also explores bone mineral density in patients with rheumatoid arthritis under different biologic and targeted synthetic treatment strategies, highlighting the importance of ongoing bone health monitoring, individualized therapy decisions, and the need for additional research before applying these findings broadly in clinical practice.

Stay tuned for the next episode in the EULAR 2026 Osteoporosis RhAPP Up Series. For more rheumatology education, visit the RhAPP Content Rheum and RhAPP ACE Mobile App.